Skip to main content
Erschienen in: Reactions Weekly 1/2012

01.08.2012 | Case report

Entecavir

Development of entecavir resistance in hepatitis B virus infection: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literatur
1.
Zurück zum Zitat Lee HW, Kim HJ, Hong SP, Cha BK, Chang HY, Choi CH, Do JH, Kim JG, Chang SK.Simultaneous emergence of entecavir resistance mutations in a nucleoside-naive chronic hepatitis B patient. Intervirology 55: 380-384, No. 5, May 2012. Available from: URL: http://dx.doi.org/10.1159/000336561 - South Korea Lee HW, Kim HJ, Hong SP, Cha BK, Chang HY, Choi CH, Do JH, Kim JG, Chang SK.Simultaneous emergence of entecavir resistance mutations in a nucleoside-naive chronic hepatitis B patient. Intervirology 55: 380-384, No. 5, May 2012. Available from: URL: http://​dx.​doi.​org/​10.​1159/​000336561 - South Korea
Metadaten
Titel
Entecavir
Development of entecavir resistance in hepatitis B virus infection: case report
Publikationsdatum
01.08.2012
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2012
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201214140-00080

Weitere Artikel der Ausgabe 1/2012

Reactions Weekly 1/2012 Zur Ausgabe

Case report

Propolis

Case report

Citalopram

Case report

Omeprazole

Case report

Antibacterials